[go: up one dir, main page]

GB201305503D0 - Inhibitor - Google Patents

Inhibitor

Info

Publication number
GB201305503D0
GB201305503D0 GBGB1305503.3A GB201305503A GB201305503D0 GB 201305503 D0 GB201305503 D0 GB 201305503D0 GB 201305503 A GB201305503 A GB 201305503A GB 201305503 D0 GB201305503 D0 GB 201305503D0
Authority
GB
United Kingdom
Prior art keywords
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1305503.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Warwick
Original Assignee
University of Warwick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Warwick filed Critical University of Warwick
Priority to GBGB1305503.3A priority Critical patent/GB201305503D0/en
Publication of GB201305503D0 publication Critical patent/GB201305503D0/en
Priority to PCT/GB2014/050943 priority patent/WO2014155097A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/11Antisense
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/32Chemical structure of the sugar
    • C12N2310/323Chemical structure of the sugar modified ring structure
    • C12N2310/3231Chemical structure of the sugar modified ring structure having an additional ring, e.g. LNA, ENA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/35Nature of the modification
    • C12N2310/351Conjugate
    • C12N2310/3519Fusion with another nucleic acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/50Physical structure
    • C12N2310/53Physical structure partially self-complementary or closed
    • C12N2310/533Physical structure partially self-complementary or closed having a mismatch or nick in at least one of the strands

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1305503.3A 2013-03-26 2013-03-26 Inhibitor Ceased GB201305503D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1305503.3A GB201305503D0 (en) 2013-03-26 2013-03-26 Inhibitor
PCT/GB2014/050943 WO2014155097A1 (en) 2013-03-26 2014-03-25 Inhibitor for treatment of hcv infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1305503.3A GB201305503D0 (en) 2013-03-26 2013-03-26 Inhibitor

Publications (1)

Publication Number Publication Date
GB201305503D0 true GB201305503D0 (en) 2013-05-08

Family

ID=48326676

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1305503.3A Ceased GB201305503D0 (en) 2013-03-26 2013-03-26 Inhibitor

Country Status (2)

Country Link
GB (1) GB201305503D0 (en)
WO (1) WO2014155097A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201114391D0 (en) * 2011-08-19 2011-10-05 Univ Warwick Method

Also Published As

Publication number Publication date
WO2014155097A1 (en) 2014-10-02

Similar Documents

Publication Publication Date Title
ZA201506156B (en) Novel inhibitors
ZA201506516B (en) Hdac inhibitors
GB201317609D0 (en) Inhibitor compounds
GB201306718D0 (en) Eazzypress
GB201304236D0 (en) Hand-warmer
AU353643S (en) Stamphousing
GB201311616D0 (en) Clip-gun-magazine
DK3056208T3 (en) Immunpotentiator
EP3014557A4 (en) Phone-on-file
GB201300001D0 (en) Envirep - environment replicater
GB201305503D0 (en) Inhibitor
GB201321328D0 (en) Inhibitor compounds
AU4953P (en) Flogazora Gazania rigens
GB201307906D0 (en) Corrosion inhibitor
AU353331S (en) Kettlebell
AU353325S (en) Kettlebell
GB201318182D0 (en) Inhibitor peptides
AU353341S (en) Playsuit
AU354283S (en) Playsuit
GB201311070D0 (en) Drydam
GB201310746D0 (en) SwivelGrips
GB201310342D0 (en) Myemailguru
GB201310423D0 (en) Fone2Find
GB201309922D0 (en) C-garette
GB201309078D0 (en) SaleCloud

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)